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ABSTRACT
Topoisomerase IIa interacts with numerous
nuclear factors, through which it is engaged in
diverse nuclear events such as DNA replication,
transcription and the formation or maintenance of
heterochromatin. We previously reported that topo-
isomerase IIa interacts with RNA helicase A (RHA),
consistent with a recent view that topoisomerases
and helicases function together. Intrigued by our
observation that the RHA–topoisomerase IIa inter-
action is sensitive to ribonuclease A, we explored
whether the RHA–topoisomerase IIa interaction
can be recapitulated in vitro using purified proteins
and a synthetic RNA. This work led us to an
unexpected finding that an RNA-binding activity
is intrinsically associated with topoisomerase IIa.
Topoisomerase IIa stably interacted with RNA har-
boring a 3’-hydroxyl group but not with RNA posses-
sing a 3’-phosphate group. When measured in
decatenation and relaxation assays, RNA binding
influenced the catalytic function of topoisomerase
IIa to regulate DNA topology. We discuss a possible
interaction of topoisomerase IIa with the poly(A) tail
and G/U-rich 3’-untranslated region (3’-UTR) of
mRNA as a key step in transcription termination.
INTRODUCTION
Topoisomerase IIa is a multifunctional enzyme that
catalyzes the relaxation of supercoiled DNA, decatena-
tion of interlinked DNA and unknotting of intramolecu-
larly linked DNA by passing a DNA helix through
a transient double-strand break in a second helix (1,2).
Consistent with its role in chromosome segregation, topo-
isomerase II was identiﬁed as ScI (scaﬀold-1), a major
component of mitotic chromosomes together with ScII
(3). By employing a temperature-sensitive top2 mutant
in yeast (4–6) or utilizing topoisomerase II-speciﬁc inhibi-
tors (7,8), it was demonstrated that topoisomerase II
is involved in chromosome condensation. In addition,
when topoisomerase II function is blocked after chromo-
some condensation, cells are arrested at metaphase and
chromatids fail to separate (5,9,10). Thus, it is likely that
a topoisomerase II-mediated decatenation reaction not
only facilitates chromosome condensation but also plays
an important role in chromosome segregation.
Topoisomerases are also implicated in RNA metabol-
ism. In 1987, Liu and Wang (11) proposed ‘the twin super-
coil model’ to explain the generation of negative supercoils
and positive supercoils during transcription and their sub-
sequent removal by topoisomerase I and gyrase, respec-
tively. Since then, accumulating experimental evidence
in both prokaryotes and yeast support critical roles for
topoisomerases in transcription (12–16). In Drosophila,
topoisomerase II interacts with at least three factors,
including SCF (supercoiling factor) (17), CHRAC
(chromatin accessibility complex) (18) and HDAC1/2
(histonedeacetylase1and2)inNuRD(nucleosomeremod-
eling and deacetylase) complex (19). SCF and topoisomer-
ase II function jointly to introduce negative superhelical
turns into DNA in vitro and co-localize to puﬀs on
polytene chromosomes (17), implying a role for the SCF–
topoisomerase II complex in transcription. Although it is
dispensableforthenucleosomespacingactivityofCHRAC
in vitro, topoisomerase II is critical for the in vivo
function of CHRAC (18). The involvement of topoisomer-
aseIIintranscriptionhasalsobeensuggestedbytherepres-
sion of genes containing Polycomb group (PcG) target
sequences in Drosophila. (20). A co-repressor function of
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that it interacts with histone deacetylases HDAC1/2 con-
stituting the NuRD complex that exhibits ATP-dependent
nucleosome remodeling activity (19).
A role for topoisomerase IIa in RNA metabolism has
also been implied from its physical association with
nucleolus-derived cytoplasmic foci (NDF) in telophase
(21) and from its co-immunoprecipitation with nucleo-
phosmin/B23 (22), which is a known component of
NDF (23). In addition, Tani and co-workers (24) isolated
ﬁve yeast mutants (ptr7 to ptr11) that accumulate
poly(A)
þ RNA at a nonpermissive temperature. Among
them, ptr11 exhibited the ‘cut’ (cell untimely torn) pheno-
type and generated anucleolate nuclei. Nuclear accumula-
tion of poly(A)
þ mRNA was observed only in anucleolate
nuclei and only for intron-containing transcripts. Unex-
pectedly, ptr11
þ gene was identiﬁed as top2
þ that encodes
topoisomerase II, implying a role for topoisomerase II in
nucleolus-dependent mRNA export.
Consistent with the postulated roles for topoisomerase
II in RNA metabolism summarized above, we previously
reported the interaction of topoisomerase IIa with RNA
helicase A (RHA) in an RNase-sensitive manner (25,26).
Being a member of the DEAH family of ATPase proteins
(27–32), RHA plays a critical role in mammalian develop-
ment (33) and mediates the interaction between CBP/p300
and RNA polymerase II (34). Similarly, lethality of
mouse embryos lacking topoisomerase IIa but not its
isoenzyme topoisomerase IIb testiﬁes to the essential
roles played by topoisomerase IIa during development
(35,36). Like topoisomerase IIa, RHA also participates
in diverse nuclear processes, suggested by its interaction
with various nuclear factors, including the tumor suppres-
sor BRCA1 (37), HAP95 highly homologous to AKAP95
(A-kinase anchoring protein 95) (38), the SMN (survival
motor neuron) complex (39), an E2-type ligase Ubc9 (40),
the RISC (RNA-induced silencing complex) (41) and a
NF90/45 (nuclear factor 90/45) complex involved in mito-
tic control (42). As a preliminary investigation into their
conjoint nuclear function, we tested whether the RHA-
topoisomerase IIa interaction can be recapitulated
in vitro using puriﬁed proteins. This study led us to an
unexpected discovery that an RNA-binding activity is
intrinsically associated with topoisomerase IIa.
MATERIALS AND METHODS
Protein, DNA and RNA
Preparation of recombinant RHA and MLE used in
the present study is described previously (26,29,30).
Topoisomerase IIa was either prepared as described pre-
viously (26) or obtained from Vaxron (USA). Supercoiled
pBluescript II KS
  (pBSKS
 ) used in relaxation assay was
prepared using the Qiagen plasmid kit and Tetrahymena
kinetoplast DNA was obtained from Vaxron. All syn-
thetic homopolymer RNAs were purchased from GE
Healthcare. Synthetic RNAs used in the electrophoresis
mobility shift assay (EMSA), including the 98 mer
ssRNA, a partial dsRNA, the 91 mer ssRNA
(Figure 3C) and 38 mer ssRNA were all prepared
as described previously (27,28). Unless otherwise indi-
cated, the speciﬁc radioactivity of all RNA substrates
was adjusted to 100 000 cpm/50 fmol of RNA. To prepare
the 39 mer ssRNA, 38 mer ssRNA was ﬁrst transcribed
at a speciﬁc radioactivity of 250c.p.m./50fmol. After gel
puriﬁcation, 20 pmol of 38 mer ssRNA was end-labeled
at 378C for 1h in a reaction mixture (100ml) contain-
ing T4 RNA ligase (NEB, 20U) and a-
32P-Cp (200mCi).
Speciﬁc radioactivity was  300000 cpm/50fmol, as
determined by standard TCA precipitation. End-labeled
39 mer ssRNA was again gel-puriﬁed and resuspended
at 100fmol/ml as described previously (27,28).
A ﬂushed-ended dsRNA (60bp) was prepared as
follows. In brief, two complementary ssRNAs were trans-
cribed using pBSKS
þ linearized with KpnI or BamHI.
In vitro transcription reactions were conducted at 378C
for 90min in reactions (100ml) containing 40mM Tris–
HCl, pH 7.8, 10mM DTT, 0.5mM GTP/ATP/CTP,
50mM UTP, 180mCi a-
32P-UTP, 0.5 U/ml RNasin
(Promega), 2mM spermidine, 14mM MgCl2 and either
T3 or T7 RNA polymerase (Promega). Following treat-
ment with DNase I (20mg/ml) and 1mM CaCl2 at 378C
for 30min, RNAs were isolated through phenol/chloro-
form extraction and ethanol precipitation, and subse-
quently they were resuspended in DEPC-treated water
(3.3ml) and combined. The RNA solution was heated to
1008C and mixed with 16.7ml of a hybridization buﬀer
(0.24M PIPES, pH 6.4, 2.4M NaCl and 6mM EDTA)
and formamide (80ml). After incubation at 508C for 1h,
RNAs were repuriﬁed and digested with RNase A
(1mg/ml) and RNase T1 (10 U) at 208C for 1h. The
dsRNA was then gel-puriﬁed as described previously
(28). Unless otherwise indicated, the speciﬁc radioactivity
of all RNA substrates was adjusted to 100 000c.p.m./50
fmol of RNA.
Electrophoresis mobility shift assay(EMSA)
A standard EMSA reaction (20ml) contained 20mM
HEPES-NaOH, pH 7.4, 2mM DTT, 3mM MgCl2,
0.05% NP-40, substrate RNA (1.25–2.5nM), and indi-
cated amounts of topoisomerase IIa, MLE or RHA.
After incubation for 30min at 378C, reaction mixtures
were transferred on ice and mixed with 5mlo f5  dye-
mix consisting of 0.1M Tris–HCl, pH 7.4, 0.1% bromo-
phenol blue, 0.1% xylene cyanol, 0.1% NP-40 and
50% glycerol. RNA–protein complexes were resolved on
a composite gel containing 5% (60:1) polyacrylamide and
5% glycerol in 0.5 TBE. RNA–protein complexes were
visualized by autoradiography and quantiﬁed using a
PhosphorImager (Molecular Dynamics).
Decatenation and relaxation assays
Standard reaction mixture (10ml), used to measure
both decatenation and relaxation activities of topoisom-
erase IIa, consisted of 50mM Tris–HCl, pH 8.0, 0.1M
NaCl, 10mM MgCl2, 0.5mM DTT, 0.5mM ATP,
0.2mg/ml BSA with indicated amounts of topoisomerase
IIa and either Tetrahymena kinetoplast DNA (0.5mg) or
pBSKS
  (0.25mg) as substrate. Unless otherwise indi-
cated, decatenation and relaxation reactions were carried
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quently they were mixed with 1ml each of SDS (6%) and
proteinase K (3mg/ml). Following a 30-min incubation
at 378C, reaction mixtures were provided with 3mlo f
5 dye-mix described above and loaded on a 1% agarose
gel in 1 Tris–acetate/EDTA (TAE) buﬀer, pH 8.0.
DNAs were visualized by ethidium bromide (0.5mg/ml)
staining for 20–45min and quantiﬁed using a Gel Docu-
mentation System (Bio-Rad).
Sedimentation analysis
An aliquot (60mg) of topoisomerase IIa was loaded
on a linear glycerol gradient (4.8ml, 20–40%) in a
buﬀer containing 20mM HEPES-NaOH, pH 7.4, 0.2M
KCl, 0.2mM EDTA, 1mM DTT and 0.05% NP-40.
After centrifugation at 45 000 r.p.m. for 27h at 48Ci na
Beckman 55TiSw rotor, 27 fractions were collected and
tested for the presence of topoisomerase IIa, decatenation
activity and RNA-binding activity. First, distribution of
topoisomearse IIa was determined by analyzing aliquots
(10ml) of glycerol fractions on a 7.5% SDS–PAGE,
followed by Coomassie staining. Decatenation activity of
each glycerol fraction was examined with aliquots (1ml) of
1:100 diluted fraction in the standard decatenation assay
described above. One unit of decatenation activity equals
complete decatenation of 1mg of kinetoplast DNA in 1h.
Aliquots (0.5ml) of glycerol fractions were assayed for
binding activity to a 91 mer ssRNA (1.7nM) in a standard
EMSA as described above. RNA–topoisomerase IIa com-
plexes, resolved on a native gel, were quantiﬁed using
a PhosphorImager. One unit of RNA-binding activity is
deﬁned as forming complexes with 10 fmol of ssRNA
in 30min at 378C.
RESULTS
Topoisomerase IIadirectly interactswith RNA
We previously reported that the in vivo interaction of
topoisomerase IIa with RHA is sensitive to RNase A
treatment (26). Several possibilities can be considered for
the molecular nature of their interaction. For example,
since RHA possesses a demonstrated RNA-binding activ-
ity (28–30) and the RHA–topoisomerase IIa interaction
is cell cycle-speciﬁc (25), there might exist RNAs that
associate with RHA, spatiotemporally enabling it to inter-
act with topoisomerase IIa. Alternatively, there might
be an as-yet-unidentiﬁed factor that bridges the RHA–
topoisomerase IIa interaction in an RNA-dependent
manner. To test these possibilities, we explored whether
RHA–topoisomerase IIa interaction can be recapitulated
utilizing in vitro transcribed synthetic RNAs.
As described in our previous report, RHA and topo-
isomerase IIa were isolated from HeLa cells (26), whereas
MLE, the Drosophila counterpart of RHA, was prepared
as a recombinant protein using baculovirus (30). In an
EMSA, both RHA and MLE (6.9nM) stably interacted
with either a 98 mer ssRNA (1.25nM) or a partial
dsRNA (2.5nM) (Figure 1, lanes 2, 6, 11 and 15).
Unexpectedly, increasing concentrations of topoisomerase
IIa (1.47–5.88nM) appeared to compete out RHA and
MLE for the interaction with ssRNA (lanes 3–4 and
7–8) or dsRNA (lanes 12–13 and 16–17). More intrigu-
ingly, topoisomerase IIa alone formed stable complexes
with both ssRNA (lanes 5 and 9) and dsRNA (lanes 14
and 18). Although it is yet to be determined whether there
exists any physical contact between topoisomerase IIa and
RHA or MLE within such complexes, a direct binding of
topoisomerase IIa to RNA suggests that a more complex
Figure 1. Detection of an RNA-binding activity associated with topoisomerase IIa. EMSA was performed with 98 mer ssRNA (1.25nM, lanes 1–9)
or a partial dsRNA (2.5nM, lanes 10–18), and MLE (10ng, lanes 2–4 and 11–13) or RHA (10ng, lanes 6–8 and 15–17). Topoisomerase IIa
(5 or 20ng) was also included in the indicated reactions (lanes 3–5, 7–9, 12–14 and 16–18). RNA–protein complexes were resolved on a composite
gel, as described in Materials and Methods section, and visualized by autoradiography and quantiﬁed by PhosphorImager analysis (Molecular
Dynamics).
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exist than was initially speculated.
Characterization of RNA-binding activity of
topoisomerase IIa
That topoisomerase IIa can react with RNA is not
unprecedented. Wang et al. (43) reported that human
topoisomerase IIa and IIb catalyze the cleavage of ribonu-
cleotide-containing substrate more eﬃciently than DNA
substrate. Earlier work also described that Escherichia
coli topoisomerase III, a type IA topoisomerase, catalyzes
anRNAstrandpassagereaction,formingcovalentlylinked
RNA–protein intermediates (44). In addition, type IB
topoisomerases, human and vaccinia virus topoisomerase
I, catalyze site-speciﬁc endoribonucleolytic cleavage of
synthetic linear substrate, DNApRNA, harboring ribo-
nucleotide sequence in the pentapyrimidine recognition
site, 50-CCCTU or 50-CCCUU (45). In further support
of the topoisomerase–RNA interaction, Fisher and
coworkers (46) showed that the majority of Drosophila
topoisomerase II is associated with DNA in interphase
but in mitosis the vast majority of soluble topoisomerase II
associates with RNA.
Although topoisomerases all share an ability to react
with RNA, be it as part of linear or circular DNA–
RNA hybrid, their interaction with RNA, in particular
with cellular RNA, has never been studied. Therefore,
we attempted to further characterize the RNA-binding
activity of topoisomerase IIa utilizing linear RNAs in
diﬀerent conformations such as ssRNA (Figure 2A,
lanes 1–4), partial duplex RNA (dsRNA) (Figure 2A,
lanes 5–8) and ﬂush-ended dsRNA (Figure 2B). Both
ssRNA and dsRNA (2.5nM) were eﬃcient in interacting
with topoisomerase IIa (7.35–29.4nM) (Figure 2A).
Interaction of topoisomerase IIa (7.35–29.4nM) with a
60-bp ﬂush-ended RNA (2.5nM) was less eﬃcient than
that with RNAs containing single-stranded regions
(Figure 2B). Despite apparent engagement of all ssRNA
or dsRNA in the formation of complex with
Figure 2. Characterization of the RNA-binding activity associated with topoisomerase IIa.( A) Either ssRNA or a partial dsRNA (2.5nM)
was incubated with an increasing amount of topoisomerase IIa (7.35, 14.7 or 29.4nM) in a reaction mixture (10ml) consisting of 20mM
HEPES-NaOH, pH 7.4, 2mM DTT, 0.05% NP-40 and 7mM MgCl2.( B) ATP (2mM) or (C) increasing concentration of salt (0–300mM)
was included in a standard reaction mixture (see Materials and Methods section), containing topoisomerase IIa (7.35nM) and 60-bp ﬂush-ended
dsRNA. (D) Supershift assay was performed by sequentially incubating topoisomerase IIa (7.35nM) (lanes 2–4 and 6–7) with 60-bp ﬂush-ended
dsRNA and monoclonal antibody (0.125 or 0.25mg) speciﬁc for the C-terminal domain of topoisomerase IIa (aa 1245–1361) (lanes 3–5). All RNA–
topoisomerase IIa complexes were detected as described in Figure 1.
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and 6), higher concentrations of topoisomerase IIa
(14.7–29.4nM) resulted in further retardation of RNA–
protein complexes (compare lanes 2 and 6 to lanes 3–4
and 7–8, respectively). This result suggests that a 98-mer
ssRNA is capable of associating with more than one
topoisomerase IIa molecule. At the highest concentration
(29.4nM) of topoisomerase IIa, all RNA substrates failed
to enter the gel (Figure 2A, lanes 4 and 8; Figure 2B, lane 4).
We also determined the inﬂuence of ATP or increasing salt
concentration on the topoisomerase IIa–RNA interaction.
Neither the presence of ATP (2mM) (Figure 2B, lanes 5–8)
nor increasing concentration of NaCl up to 100mM
(Figure 2C) signiﬁcantly aﬀected the topoisomerase IIa–
RNA interaction. The topoisomerase IIa–RNA interaction
persisted even in the presence of higher NaCl concentration
up to 300mM, though with reduced eﬃciency (Figure 2C).
These results indicate that the topoisomerase IIa–RNA
interactioncanoccurundernormalphysiologicalconditions
even in the absence of ATP.
RNA-binding activity isintrinsically associated with
topoisomerase IIa
Since a direct and stable association with RNA has not
been reported for any topoisomerases prior to our work,
we asked whether such RNA-binding activity is intrinsi-
cally associated with topoisomerase IIa or with an as-yet-
unidentiﬁed factor that is co-puriﬁed with topoisomerase
IIa. First, we performed an antibody-driven super-
shift assay. Topoisomerase IIa (7.35nM) was sequentially
incubated with a 60-bp ﬂush-ended RNA and monoclonal
antibody (0.125 or 0.25mg) speciﬁc for the C-terminal
domain of topoisomerase IIa (aa 1245–1361) or for
hemaglutinin (HA) epitope, KAFSNCYPYDVPDYAS
LRS. As shown in Figure 2D, topoisomerase IIa–RNA
complex was shifted only by monoclonal antibody speciﬁc
for topoisomerase IIa (compare lanes 3–4 and 6–7).
Second, topoisomerase IIa was subjected to ultracentri-
fugal separation through glycerol gradient (20–40%),
and subsequently, distribution of decatenation activity,
a signature and intrinsic function of topoisomerase IIa,
was determined in comparison with that of RNA-binding
activity. When aliquots of gradient fractions were ana-
lyzed by SDS–PAGE, topoisomerase IIa was enriched in
fractions 17–19 with an estimated sedimentation coeﬃ-
cient of 10.83S (Figure 3A). Together with a Stokes
radius of 7.2nm, obtained by Superose 6HR chromato-
graphy (data not shown), a native molecular weight of
topoisomerase IIa was calculated to be  322kDa with
a friction coeﬃcient of 3.4 according to the method of
Siegel and Monty (47). Since the predicted molecular
weight of topoisomerase IIa is 174.4kDa (GenBank acces-
sion no. NP_001058), our result indicates that human
topoisomerase IIa enriched in gradient fractions 17–19,
is a rod-shape homodimer, similar to topoisomerase II
from other organisms, including Drosophila (48) and
bovine (49). Distribution of decatenation activity
(Figure 3B), measured with catenated Tetrahymena kine-
toplast DNA, and RNA-binding activity (Figure 3C)
exhibited a sedimentation pattern identical to each other
Figure 3. Sedimentation analysis of biochemical activities associated with topoisomerase IIa. Sedimentation analysis was performed using topo-
isomerase IIa (60mg) and a linear glycerol gradient (4.8ml, 20–40%). After centrifugation at 45000 r.p.m. for 27h at 48C in a Beckman 55TiSw
rotor, 27 fractions were collected. All numbers represent the fraction numbers from the glycerol gradient. (A) Aliquots (10ml) were subjected to 7.5%
SDS–PAGE, and proteins were visualized by Coomassie staining. (B) Glycerol fractions were diluted 1:100, and 1-ml aliquots were tested for
decatenation activity of kinetoplast DNA (0.5mg). After a 30-min incubation at 378C, reaction mixtures were resolved on 1% agarose gel, and
monomer circles were quantiﬁed using a Gel Doc system (Bio-Rad) and presented in (D). (C) Aliquots (0.5ml) of glycerol fractions were examined for
RNA-binding activity using a 91 mer ssRNA (1.7nM), which is derived from the 30-UTR of human TNF-a mRNA, as described in Materials and
methods section. RNA–topoisomerase IIa complexes were resolved on a native gel, detected by autoradiography and quantiﬁed as described
in Figure 1.
6084 Nucleic Acids Research, 2008, Vol. 36, No. 19(Figure 3D) and to that of topoisomerase IIa (Figure 3A).
Since there was no other protein that co-sedimented
with topoisomerase IIa or co-migrated with RNA-
binding activity on glycerol gradient, we conclude that
RNA-binding activity is associated with a homodimeric
topoisomerase IIa.
Topoisomerase IIaand RHA exhibit differential
RNA-binding specificity
As discussed above, stable interaction between topoisome-
rase IIa and RHA is dependent upon the presence of
RNA (26). Although it remains unknown whether speciﬁc
RNAs bridge their interaction, it would be informative
to compare RHA and topoisomerase IIa for their RNA-
binding property, in particular, from the aspect of RNA
sequence speciﬁcity. As shown in Figure 4A, topoisomer-
ase IIa (7.35nM) was incubated with a 98 mer ssRNA
(2.5nM) in the presence of increasing concentration
(6 or 30nM) of the indicated synthetic homopolymer
RNA. Parallel reactions were provided with RHA
(6.9nM) in place of topoisomerase IIa and a ﬁxed con-
centration (30nM) of the indicated competitor RNA.
Among all competitor RNAs tested, only poly(G) and
poly(I) were inhibitory to the RHA–RNA interaction
(lanes 13–18). Similarly, topoisomerase IIa–RNA
Figure 4. Comparative analysis of RNA-binding activities associated with topoisomerase IIa and RHA. (A) Topoisomerase IIa (7.35nM) or RHA
(13.8nM) was incubated in a standard reaction mixture (10ml) containing 98 mer ssRNA (2.5nM). Increasing concentration (6–30nM) of indicated
homopolymer RNA was included as competitor in reactions containing topoisomerase IIa (lanes 3–12), whereas a ﬁxed concentration (30nM) of
competitor RNA was added to reactions with RHA (lanes 14–18). After a 30-min incubation at 378C, RNA–protein complexes were analyzed as
described in Figure 1. (B) Increasing concentrations of topoisomerase IIa (3.7–7.35nM) or RHA (13.8–27.6nM) were incubated in a standard
reaction mixture (10ml) containing either 38 mer ssRNA with a hydroxyl group at the 30-end (lanes 1–5 and 11–15) or 39 mer ssRNA with
a phosphate group at the 30-end (lanes 6–10 and 16–20). After a 30-min incubation at 37
8C, reactions were mixed with either 5 dye mix alone
(lanes 1–10) or in combination with SDS to a ﬁnal concentration of 0.5%. Due to the diﬀerence in the speciﬁc radioactivity between 38 mer and
39 mer ssRNA, as described in Materials and Methods section, the entire mixture was loaded on a gel for reactions containing 38 mer ssRNA
(lanes 1–5 and 11–15), whereas 5-ml aliquots were analyzed for reactions provided with 39 mer ssRNA (lanes 6–10 and 16–20). Subsequently, RNA–
protein complexes were examined as described in Figure 1. (C) RHA (13.8nM) (lanes 2 and 4) or topoisomerase IIa (3.7nM) (lanes 3 and 5) was
reacted with 38 mer ssRNA as described in (B). After a 30-min incubation at 37
8C, all reactions were mixed with SDS (0.5%) and proteinase K
(0.25mg/ml) and incubated for an additional 30min. Subsequently, 5 dye mix was added, and the mixture was either directly loaded on a gel
(lanes 1–3) or preheated at 95
8C for 5min (lanes 4–5).
Nucleic Acids Research, 2008, Vol. 36, No. 19 6085interaction was severely impaired by poly(G) and poly(I).
However, all competitor RNAs seemed to aﬀect the topo-
isomerase IIa–RNA interaction to varying degrees. This
result indicates that the RHA–RNA interaction is more
sequence-speciﬁc than the topoisomerase IIa–RNA
interaction.
Recently, Dong et al. (50) reported that La protein pos-
sesses the ability to discriminate between RNAs that bear
30-OH versus 30-PO4. They proposed that this discrimina-
tion is potentially important for La proteins to recognize
newly synthesized RNAs and to distinguish them from
RNase-degraded RNA that contains 30-PO4. We specu-
lated that like La protein, topoisomerase IIa–RNA inter-
action might be inﬂuenced by the identity of the 30-end of
RNA. To test this possibility, a 39 mer ssRNA containing
30-PO4 was generated by ligating 38 mer ssRNA to
cytidine 30,50-bisphosphate using T4 RNA ligase. The
resulting 39 mer RNA was compared to its precursor
38 mer RNA for the ability to associate with RHA and
topoisomerase IIa.
Both 38 and 39 mer RNA were poorly engaged in the
formation of stable complex with RHA (13.8–27.6nM)
without noticeable diﬀerence (Figure 4B, compare lanes
2–3 and 7–8). Overall eﬃciency of the formation of
stable complexes with RHA was much lower for both
38 and 39 mer RNAs than for 98 mer RNA (Figure 4A,
lane 13), suggesting that the length of RNA is a factor that
inﬂuences eﬃcient association with RHA. In contrast,
38 mer and 39 mer RNA exhibited a noticeable diﬀerence
in the formation of stable complex with topoisomerase IIa
(7.35–14.7nM). Compared to RHA, the ability of topo-
isomerase IIa to bind RNA was relatively unaﬀected by
RNA length (compare Figure 4A, lane 2 and Figure 4B,
lanes 4–5). Although the vast majority of 38 mer RNA
appeared to interact with topoisomerase IIa only a small
fraction (19 or 32%) of 38 mer RNA was engaged in the
formation of ‘stable’ complex with topoisomerase IIa
(Figure 4B, lanes 4–5). In addition, quantiﬁably more
stable topoisomerase IIa–38 mer RNA complex was
formed than was topoisomerase IIa–39 mer RNA com-
plex (Figure 4B, compare lanes 4–5 and 9–10). Coinci-
dently, the formation of unstable complexes, giving
rise to smeared RNA signals, was increased when topo-
isomerase IIa was bound to 39 mer RNA (Figure 4B,
lanes 9–10). These results suggest that the stable associa-
tion of topoisomerase IIa with RNA is more inﬂuenced
by the 30-OH group than RNA length.
DiGate and Marians (44) reported that E. coli topo-
isomerase III catalyzes site-speciﬁc cleavage of ssRNA as
short as 30-nt long, forming a covalent RNA–topoisome-
rase III intermediate. Sekiguchi and Shuman (45) made a
similar observation with Vaccinia virus topoisomerase I.
To examine whether the topoisomerase IIa–RNA interac-
tion involves the formation of covalent linkage similar
to type I topoisomerases, topoisomerase IIa- and RHA–
RNA complexes were treated with SDS and analyzed for
RNA (Figure 4B, lanes 11–20). Treatment with SDS
(0.5%) and proteinase K (0.25mg/ml) did not alter the
migration of substrate RNAs (compare lanes 1, 6, 11
and 16). However, interaction with topoisomerase IIa gen-
erated a slowly migrating form (lanes 14–15 and 19–20).
RHA yielded a similar result but more eﬃciently with
39 mer RNA than with 38 mer RNA (compare lanes
12–13 and 17–18). The slowly migrating RNA is likely
to be a structured form of RNA since heat treatment
(958C, 5min) resulted in their conversion to a faster
migrating form of RNA (Figure 4C). Although the iden-
tity of structured RNA remains to be determined, the
above result excludes the possibility of covalent modiﬁca-
tion of ssRNA substrates by topoisomerase IIa.
Implication of topoisomerase IIain RNA metabolism
What would be the physiological signiﬁcance of topo-
isomerase IIa binding to RNA? There might exist an
as-yet-unknown RNA that modulates the ability of topo-
isomerase IIa to interact with other factors such as RHA
or to regulate DNA topology. Alternatively, RNA meta-
bolism might be inﬂuenced by topoisomerase IIa.A sa n
initial attempt toward testing these possibilities, we ﬁrst
explored whether RNA inﬂuences the ability of topoisom-
erase IIa to regulate DNA topology. For this purpose,
we measured the decatenation activity of topoisom-
erase IIa (0.6nM) in reactions containing Tetrahymena
kinetoplast DNA (0.5mg) and varying concentrations
(0.8–57nM) of synthetic homopolymer RNAs. As shown
in Figure 5, RNA brought about diverse eﬀects on
topoisomerase IIa. In brief, poly(A) and poly(C) were
noninﬂuential, whereas poly(G), poly(I) and poly(U)
were inhibitory (Figure 5A). IC50 was estimated to be
0.5–1.5nM, which was obtained from four indepen-
dent experiments provided with the indicated RNA
(0.6–8nM) (Figure 5B). We asked whether this diverse
eﬀect is governed by base sequence alone or in combina-
tion with the sugar moiety (i.e. ribose versus deoxyribose).
In the former case, both RNA and DNA homopolymer
of the same sequence would elicit similar eﬀects on the
decatenation activity of topoisomerase IIa. In order to
test this possibility, a kinetic analysis was performed in
reactions for the decatenation activity in the presence of
poly(A) or poly(dA). As shown in Figure 5C, in contrast
to poly(A), which even appeared to be slightly stimula-
tory, poly(dA) inhibited decatenation activity of topo-
isomerase IIa (Figure 5C). This result indicates that the
eﬀects observed in Figure 5A and B have to do with both
the base sequence and identity of sugar moiety.
The eﬀects of RNA were also examined for the
relaxation activity of topoisomerase IIa. For this purpose,
in vitro relaxation of supercoiled plasmid DNA (pBSKS
 )
was measured in reactions provided with three diﬀerent
concentrations (0.6, 2.4 and 6.0nM) of synthetic RNA.
As shown in Figure 5D, poly(G) and poly(I) but not
poly(A) and poly(C) were inhibitory. In contrast to its
eﬀect on the decatenation activity of topoisomerase IIa,
poly(U) did not signiﬁcantly aﬀect the relaxation activity
of topoisomerase IIa. This result raises an intriguing
possibility that the decatenation and relaxation activity
of topoisomerase IIa could be subject to diﬀerential regu-
lation by an RNA molecule, depending on the base
sequence. Together with the result in Figure 4A, the
above result may also indicate that the stability and speci-
ﬁcity of the RNA-binding activity of topoisomerase IIa is
6086 Nucleic Acids Research, 2008, Vol. 36, No. 19RNA sequence-speciﬁc. In this regard, a report by Ideue
et al. (24) is particularly noteworthy. In an attempt to iden-
tify novel factors involved in mRNA export, they screened
a yeast ts mutant bank using in situ hybridization (FISH)
with an oligo(dT) probe. The authors described one partic-
ular mutant ptr11 and two of its alleles that displayed both
the ‘cut’ phenotype and nuclear accumulation of poly(A)
þ
RNA. Cloning of ptr11 revealed that the ORF is top2
þ
coding for topoisomerase II. The ﬁnding that nuclear
accumulation of poly(A)
þ RNA is observed only in the
anucleolate nuclei led the authors to hypothesize that
the nucleolus is required for mRNA export in yeast.
Although the underlying mechanisms remain unknown,
this observation strongly suggests a role played by topo-
isomerase II in poly(A)
þ RNA export. Based on the results
shown in Figure 5, we predict that topoisomerase II
sequentially interacts with the (G/U)-rich region and
poly(A)
þ tail of the transcript to regulate the template
DNA topology in coordination with transcription termina-
tion and poly(A)
þ RNA export (see Discussion section).
DISCUSSION
In this report, we identify a novel RNA-binding activity
of topoisomerase IIa. Our observation that RNA associa-
tion with topoisomerase IIa modulated the ability of
Figure 5. Inﬂuence of homopolymer RNA on the ability of topoisomerase IIa function to regulate DNA topology. (A) Decatenation reaction was
carried out in a standard reaction mixture (10ml) containing kinetoplast DNA (0.5mg) and the indicated RNA homopolymer. Lane 1; control
reaction without topoisomerase IIa. Lanes 2–17; with topoisomerase IIa (0.6nM). Lanes 3–5; 0.8, 3.1 and 7.70nM poly(A). Lanes 6–8; 5.7, 23 and
57nM poly(G). Lanes 9–11; 1.1, 4.5 and 11nM poly(C). Lanes 12–13; 1.5, 6.2 and 15nM poly(U). Lanes 15–17; 0.6, 2.6 and 6.4nM poly(I).
(B) Decatenation reaction was performed at 37
8C for 20min in a standard reaction mixture containing topoisomerase IIa (0.6nM) and varying
concentrations (0–8nM) of homopolymer RNA. Following treatment with proteinase K (0.25mg/ml) and SDS (0.5%), reaction mixtures were
resolved on a 1% agarose gel, and both kinetoplast DNA and decatenated monomer were visualized by ethidium bromide staining and quantiﬁed
using a Gel-Documentation System (Bio-Rad), as described in Materials and Methods section. The 100% decatenation activity is an arbitrary unit
that equals the amount of monomer circle produced by topoisomerase IIa in the absence of synthetic homopolymer RNA (lane 2). Decatenation
activity was measured in four independent experiments, and their average values are presented with error bars. (C) Decatenation reaction, provided
with topoisomerase IIa (0.6nM) and indicated homopolymer (0.1mg) in a standard reaction mixture (10ml), was incubated at 37
8C for increasing
periods of time (2, 5, 10, 15, 22 and 30min). After resolving on a 1% agarose gel, decatenated DNAs were visualized by ethidium bromide staining
and quantiﬁed as described in (B). The 100% of DNA equals to the summed density of all DNA bands detected in lane 7, of which monomer circle
accounts for 94% of the total DNA. Percent-decatenated DNA represents the relative density of monomer circle obtained from each reaction.
(D) Relaxation reaction was carried out at 37
8C for 30min in a standard reaction mixture (10ml) containing topoisomerase IIa (11.8nM), 0.25mgo f
supercolied pBSKS
  DNA (0.25mg), and varying concentrations (0.6, 2.4 and 6.0nM) of the indicated RNA homopolymer. Supercoiled DNA and
its topoisomers were analyzed as described in (B).
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gest the RNA can regulate topoisomerase IIa function or
that topoisomerase IIa has a role in RNA metabolism
through its direct association with RNA in a sequence-
speciﬁc manner.
At present, the molecular basis by which poly(I),
poly(G) and poly(U) inhibit topoisomerase IIa remains
unknown. Since poly(G) and poly(I), the two highly inhib-
itory RNAs, potentially form quadruple structure (51),
they may compete with DNA substrate for topoisomerase
IIa. Consistent with this possibility, inhibitory poly(U)
forms antiparallel A-type double helices, whereas nonin-
ﬂuential poly(A) and poly(C) form only a single helix (51).
This competition model presupposes the presence of a
binding site in topoisomerase IIa commonly occupied by
structured RNA and DNA. However, it cannot explain
why poly(dA), which forms a single-stranded B-type
helix (52), was also inhibitory to topoisomerase IIa.
Alternatively, it is possible that the catalytic activity of
topoisomerase IIa may be regulated by RNA bound on
an as yet unknown domain. If this is the case, are there
any features common to the inhibitory or non-nhibitory
RNAs described here? In this regard, it should be noted
that an amino group (–NH2) is commonly present in bases
of noninhibitory RNA, whereas a keto (C¼O) group is
present in bases of inhibitory RNA. Current models on
DNA transaction catalyzed by topoisomerase II envision
the formation of scissile breaks in the phosphate backbone
of DNA by nucleophilic attack of an oxygen atom in a
conserved tyrosine residue. In bases of inhibitory RNA
such as poly(G), a change in hydrogen atom position
can lead to transformation of a keto (C¼O) group to
an enol (C–OH) group. Although the enol conﬁguration
is extremely rare in solution, interaction with topoisome-
rase IIa might increase its population suﬃciently to
interfere with the nucleophilic attack of the tyrosine
oxygen atom.
Recent studies have provided several lines of evidence
indicating a mechanistic coupling of transcription to DNA
supercoiling. In 1987, Liu and Wang (11) proposed the
twin supercoil model to explain a higher level of negative
or positive supercoils in intracellular plasmid DNA when
topoisomerase I or gyrase is inhibited. This model predicts
that the transcription process simultaneously generates
positive and negative supercoils in regions of DNA
behind and in front of the transcription elongation com-
plex, respectively. In prokaryotes, topoisomerase I prefer-
entially removes negative supercoils, while DNA gyrase
removes positive supercoils, maintaining the proper level
of supercoils in genomic DNA. Despite technical diﬃcul-
ties due to the activity of gyrase to convert positive super-
coil to negative supercoil, there is substantial evidence
supporting the twin transcription-loop model. For exam-
ple, employing a deﬁned in vitro transcription system uti-
lizing sequence-speciﬁc DNA-binding proteins and DNA
gyrase, Leng et al. (12) found that DNA supercoiling is
induced by transcription in two pathways: the ﬁrst is
dependent on the formation of the R-loop and the
second depends on a substantially long RNA transcript
(>3kb) and the presence of DNA-binding protein.
Accumulating evidence indicates critical roles for
topoisomerases in eukaryotic transcription. In 1987, Brill
et al. (53) reported severe impairment of ribosomal RNA
and poly(A)þ RNA synthesis in the Saccharomyces
cerevisiae top1top2 double mutant. Recently, Huertas
and Aguilera (54) performed a thorough phenotypic anal-
ysis of S. cerevisiae mutants of THO/TREX, a conserved
protein complex functioning at the interface of transcrip-
tion and RNA export. They found that impaired trans-
cription elongation leads to the formation of DNA: RNA
hybrids, promoting hyper-recombination. Similar to its
suppressive eﬀect on the formation of negative supercoils
induced by the R-loop in prokaryotes, overexpression of
RNase H abolished transcription-associated recombina-
tion in S. cerevisiae. In 2005, Li and Manley (55) reported
a similar observation in higher eukaryotic cells. In brief,
depletion of the splicing factor ASF/SF2 resulted in geno-
mic instability, causing accumulation of high-molecular-
weight DNA fragments. Detailed sequence analysis,
employing bisulﬁte-modiﬁcation of genomic DNA fol-
lowed by PCR sequencing, showed that template DNA
was protected from bisulﬁte modiﬁcation, most probably
due to base pairing between RNA and the DNA template.
They also reported that the formation of R-loop asso-
ciated with impaired RNA maturation was suppressed
by overexpression of RNase H.
The above observations underline that the steady-state
level of superhelicity of genomic DNA is maintained
through an intimate functional coordination of topo-
isomerases and the transcription machinery, and any per-
turbation leads to the formation of the R-loop, causing
genomic instability. That R-loop formation was primarily
observed distal from the promoter but close to the 30-end
of the gene (54), indicates a possible function for topo-
isomerase at transcription termination. Since transcription
termination, mRNA 30-end cleavage, polyadenylation and
mRNA export occur in a coupled reaction (56–58), could
topoisomerases exert their inﬂuence on this concerted
process? This scenario is supported by a recent report by
Ideue et al. (24). Their eﬀorts toward uncovering novel
factors involved in mRNA export led to the identiﬁca-
tion of one particular mutant, ptr11-1, and its two other
alleles that displayed both ‘cut’ phenotype and the nuclear
accumulation of poly(A)
þ RNA. The ptr11 gene was iden-
tiﬁed as top2
þ, coding for topoisomerase II.
Although it is unknown how topoisomerase II inﬂu-
ences transcription termination and mRNA export, the
reactivity of topoisomerase IIa with RNA may provide
a clue. Upon arrival of the transcription elongation com-
plex at the termination site, the growing chain of mRNA
undergoes drastic changes; mRNA is polyadenylated after
removal of the G/U-rich downstream element (DSE) in
the 30-untranslated region (30-UTR). Intriguingly, this
event can be viewed as sequential presentation of the
G/U-rich DSE and poly(A) tail to topoisomerase II,
through which, perhaps, the function of topoisomerase
II to regulate superhelicity of the template DNA becomes
coordinated with transcription termination, polyadenyla-
tion and mRNA export.
In addition to transcription, topoisomerase IIa has been
implicated in the formation of heterochromatin (19,59).
6088 Nucleic Acids Research, 2008, Vol. 36, No. 19Intriguingly, there is increasing evidence that small non-
coding RNAs are involved in heterochromatin formation
and maintenance (60,61). In addition, RHA interacts with
both topoisomerase IIa and the RISC complex containing
siRNA (41). Taken together, it would be worthwhile test-
ing whether topoisomerase IIa is required for the forma-
tion or maintenance of heterochromatin involving the
function of the RISC complex. In addition, it can also
be tested whether topoisomerase IIa directly interacts
with noncoding RNAs such as siRNA on heterochroma-
tin. This future study will be greatly facilitated by the
identiﬁcation of domains or amino acids critical for the
topoisomerase IIa–RNA interaction.
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